Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 3/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.43 |
| ▸ | KDM4A | O75164 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4281112 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL5542454 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL11470937 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL1006265 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL1007122 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL1006966 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL25310908 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL1007371 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL330182 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A | |
| SCHEMBL6817084 | 1.00 | SIGMAR1 (0.60) | SIGMAR1CYP1A2KDM5APHF8KDM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320175-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-10-16 | — | — | US | claimed |
| US-20250066408-A1 | Polyol-Derived Compounds | ARXADA AG (CH) | 2025-02-27 | — | — | US | claimed |
| US-20250002446-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-01-02 | — | — | US | claimed |
| US-20240336646-A1 | Polyol-Derived Compounds | ARXADA AG (CH) | 2024-10-10 | — | — | US | claimed |
| EP-4412987-A1 | ACETOACETATE BASED KETALS | Arxada AG (CH) | 2024-08-14 | — | — | EP | claimed |
| EP-4405324-A1 | POLYOL-DERIVED COMPOUNDS | Arxada AG (CH) | 2024-07-31 | — | — | EP | claimed |
| WO-2023094654-A1 | ACETOACETATE BASED KETALS | ARXADA AG (CH) | 2023-06-01 | — | — | WO | claimed |
| WO-2023083570-A1 | POLYOL-DERIVED COMPOUNDS | ARXADA AG (CH) | 2023-05-19 | — | — | WO | claimed |
| CN-110282829-B | Livestock breeding wastewater treatment method based on double-membrane solar technology | 兴源环境科技股份有限公司 | 2021-10-08 | — | — | CN | claimed |
| CN-1830987-A | Ammonium salt of cyclohexanpentol and its use | UNIV SICHUAN NORMAL (CN) | 2006-09-13 | — | — | CN | claimed |
| CN-1830986-A | Method for preparing ammonium salts of cyclohexanpentol phosphate ester | UNIV SICHUAN NORMAL (CN) | 2006-09-13 | — | — | CN | claimed |
| EP-1608350-A1 | METHODS OF PREVENTING, TREATING AND DIAGNOSING DISORDERS OF PROTEIN AGGREGATION | Ellipsis Biotherapeutics Corporation (CA) | 2005-12-28 | — | — | EP | claimed |
| WO-2004075882-A1 | METHODS OF PREVENTING, TREATING AND DIAGNOSING DISORDERS OF PROTEIN AGGREGATION | ELLIPSIS BIOTHERAPEUTICS CORPORATION (CA) | 2004-09-10 | — | — | WO | claimed |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | SYMRISE AG (DE) | 2026-03-03 | — | — | US | disclosed |
| US-20250320175-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-10-16 | — | — | US | disclosed |
| US-20250066408-A1 | Polyol-Derived Compounds | ARXADA AG (CH) | 2025-02-27 | — | — | US | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |
| US-4418058-A | ANTIBACTERIAL AGENTS | SHIONOGI & CO., LTD. (JP) | 1983-11-29 | — | — | US | disclosed |
| US-3956224-A | Preparation of powdered crosslinked polyalkylene oxides | UNION CARBIDE CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-3887590-A | Azido cyclohexanepentol derivative | LABAZ | 1975-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336646-A1 | Polyol-Derived Compounds | PARG, SQLE, PARN | SIGMAR1 3251/4885CYP1A2 518/4885KDM5A 2178/4885 |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | CUTA, HLA-A, OAT | SIGMAR1 455/4885CYP1A2 892/4885KDM5A 4043/4885 |
| US-20250002446-A1 | Acetoacetate Based Ketals | KYAT1, KAT5, ALDOA | SIGMAR1 4086/4885CYP1A2 1156/4885KDM5A 445/4885 |
| US-20250320175-A1 | Acetoacetate Based Ketals | KYAT1, KAT5, ALDOA | SIGMAR1 4086/4885CYP1A2 1156/4885KDM5A 445/4885 |
| US-20250066408-A1 | Polyol-Derived Compounds | PARG, SQLE, PARN | SIGMAR1 3251/4885CYP1A2 518/4885KDM5A 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.